AstraZeneca PLC Ordinary Shares (AZN)

Total Non-Current Assets

$87.77B

Quarterly · Period ending: · USD

AZN logo

AZN Total Non-Current Assets

Latest reported$87.77B
AZN Quarterly Non-Current Assets ($2.53B → $87.77B)
High-resolution chart · PNG

AZN total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
87,765,385,000
84,402,000,000
85,351,000,000
84,516,000,000
83,483,000,000
80,114,000,000
78,208,000,000
80,767,000,000
78,947,000,000
76,699,000,000
76,065,000,000
73,585,000,000
73,704,000,000
74,421,000,000
73,890,000,000
73,961,000,000
75,662,000,000
77,626,000,000
79,119,000,000
80,530,000,000
46,367,000,000
46,191,000,000
47,185,000,000
45,946,000,000
44,999,000,000
44,389,000,000
45,814,000,000
45,386,000,000
46,670,000,000
47,406,000,000
45,060,000,000
48,335,000,000
48,895,000,000
50,099,000,000
50,204,000,000
50,953,000,000
50,821,000,000
49,322,000,000
49,264,000,000
50,356,000,000
51,099,000,000
51,554,000,000
44,117,000,000
40,919,000,000
41,357,000,000
41,010,000,000
41,898,000,000
41,092,000,000
42,335,000,000
42,848,000,000
35,564,000,000
35,329,000,000
34,593,000,000
33,985,000,000
34,486,000,000
34,419,000,000
31,613,000,000
29,203,000,000
29,324,000,000
30,109,000,000
30,715,000,000
31,067,000,000
30,996,000,000
31,821,000,000
31,271,000,000
31,728,000,000
31,160,000,000
31,359,000,000
31,074,000,000
30,663,000,000
30,632,000,000
32,634,000,000
33,726,000,000
34,006,000,000
30,875,000,000
31,259,000,000
31,522,000,000
13,279,000,000
12,996,000,000
13,689,000,000
13,408,000,000
12,996,000,000
11,070,000,000
11,432,000,000
11,446,000,000
11,070,000,000
11,176,000,000
12,218,000,000
12,432,000,000
10,524,000,000
10,640,000,000
10,058,000,000
9,942,629,462
9,581,768,235
9,450,000,000
9,003,172,809
8,899,447,893
8,217,722,345
11,624,533,658
7,945,243,144
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.